13F filer · CIK 1831423
Vida Ventures Advisors, LLC
BOSTON, MA · filing since Q3 2020 · last filing Nov 3, 2025
Reported value
$29.4M
+$13.5M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%
Biggest buys vs Q2 2025
No new or increased positions this quarter.
Biggest sells vs Q2 2025
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | KYVERNA THERAPEUTICS INCCOM | 4,523,924 | $27.1M | 92.41% |
| 2 | ALLOGENE THERAPEUTICS INCCOM | 1,798,163 | $2.2M | 7.59% |